News & Analysis as of

IP Provisions and ROI for State-Funded Stem Cell-Based Products and Technologies in California

The California Institute of Regenerative Medicine (CIRM) reaches the end of its initial charter in 2017 and recently published its Transition Plan. The plan is a roadmap to sustained development of stem cell-based...more

1 Results
|
View per page
Page: of 1
Narrow By Topic